9 Meters Biopharma Inc (NMTRQ)

[ALERTS100%to10000%GAIN]

Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Larazotide at the 2019 Digestive Disease Week Conference in San Diego
9:46 am ET May 20, 2019 (Globe Newswire) Print
Analyst Meeting to be held at 4:30pm ET today to discuss NASH data and provide clinical updates
Three posters presented at DDW 2019 highlighted the protective effect and molecular mechanism of action of larazotide acetate in pre-clinical models via myosin light chain (MLC) phosphorylation
Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, announced today that larazotide acetate, a new class of medicine based on gut-restricted peptides which re-normalize the intestinal epithelial barrier and gut-liver axis, announced that three posters were presented on May 19 and 20, 2019 during the 2019 Digestive Disease Week (DDW) conference in San Diego, CA (Abstract Search).
Title: Larazotide acetate prevents and rescues from ethanol-induced permeability changes in an in vitro model system
Date/Time: Saturday, May 18, 2019, 12:00pm - 2:00pm PT
Poster Session Title: Alcoholic Liver Diseases - Clinical & Experimental